RLX Technologies: Recent Share Price Weakness Provides Good Entry Point

RLX Technology remains rated Buy despite expected gross-margin normalization in 2H26 after margins peaked in 2Q26. International operations now account for 70% of revenue, with recent European acquisitions expected to strengthen distribution and long-term growth. The investment case is supported by strong growth forecasts and a valuation discount to peers, though greater distributor participation and product-mix changes are expected to pressure margins.

Analysis

The key underwriting issue is whether international expansion converts into durable local-market pricing power or simply substitutes domestic regulatory concentration for a lower-margin distributor model. A greater third-party distribution mix can accelerate revenue recognition and reduce fixed-cost intensity, but it also shifts bargaining power to channel partners; if sell-through is weak, inventory destocking could surface with a one- to two-quarter lag. The European assets should be evaluated on organic sell-through, repeat-purchase rates, and contribution margin—not acquired revenue growth—before assigning a strategic premium.

Near term, the likely equity debate is multiple direction rather than earnings: investors may tolerate modest gross-margin normalization if operating expenses remain disciplined and overseas growth is demonstrably organic. Over the next 1-3 months, any guidance that frames margin pressure as temporary while international revenue continues to outgrow the group could support rerating from a discounted base. Conversely, a miss on gross margin combined with elevated receivables or inventory would indicate channel loading and could compress the multiple quickly given RLX's limited margin of safety around execution.

The contrarian view is that acquisition-led European distribution may be more valuable than headline margins imply if it creates a platform for proprietary products and direct-to-retail economics over 6-18 months. That upside requires evidence that acquired channels improve product mix and customer retention rather than merely adding low-margin volume. Regulatory risk remains the principal structural discount: a tightening in a major overseas market can impair both demand and the value of recently acquired distribution infrastructure.

Key Decisions for Investors

• Maintain a small tactical long RLX only into the next results/guidance event; add only if international growth remains above group growth while gross-margin decline is limited to management’s normalization range. Target a 10-15% upside on multiple stabilization over 1-3 months; exit if management cuts full-year margin or revenue outlook.
• Use a staged entry rather than chase post-results strength: buy one-third initially and reserve capital for a 10%+ drawdown that is not accompanied by weaker overseas sell-through, receivables deterioration, or inventory build.
• Set an operating alert for the next filing: international segment gross profit, days sales outstanding, inventory growth versus revenue, and acquisition-related integration costs. A material DSO/inventory acceleration would falsify the benign distributor-mix thesis and warrants closing the long.
• Do not express the thesis through a broad China consumer ETF; RLX’s relevant risk is cross-border nicotine regulation and channel economics, not domestic discretionary demand. Reassess position sizing immediately upon any material European flavor, tax, or product-authorization action.